Finally, our ICC assay showed that the miR-370-3p inhibitors significantly alleviated the hsa_circ_0009096 siRNA-induced downregulation of the a-SMA and COL1A1 protein levels in the LX-2 cells (Fig. 5G). The gene discussed is ACTA1; the disease is intrahepatic cholangiocarcinoma.